Ara 290 and Ipamorelin Interaction

Synergistic
Mechanism-based 47% confidence

Ara 290 and Ipamorelin have a synergistic interaction with 47% confidence. Ara 290 and Ipamorelin work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. Both compounds affect the brain, so monitoring these systems is recommended.

Compound Profiles

Ara 290

Tissue-Protective Peptide | Innate Repair Receptor Agonist

Activates IRR through EPOR/β-common receptor complex, triggering tissue-protective signaling without erythropoietic effects..

Half-life: ~20 minutes (SubQ), ~2 minutes (IV) Typical dose: 4 mg daily healing, cognitive
epo receptor hematocrit raisingteratogenic
View full profile

Ipamorelin

Growth Hormone Secretagogue | Selective GHRP

Binds selectively to ghrelin receptors in pituitary gland, stimulating natural GH release with direct systemic delivery via injection, consistent GH pulse stimulation, no significant cortisol or prolactin elevation, and minimal hunger response..

Half-life: ~2 hours Typical dose: 200-300 mcg per injection growth hormone, weight loss, sleep
ghrelin receptorprolactin receptor carcinogenic riskinsulin disruptingteratogenic
View full profile

Combined Organ Load

Brain
low
Blood Vessels
low
GI Tract
low
Pituitary
low

Shared Safety Flags

2x 2 compounds share the teratogenic safety flag (Ara 290, Ipamorelin). Monitor accordingly.

Frequently Asked Questions

Can I take Ara 290 with Ipamorelin?

Yes, Ara 290 and Ipamorelin can generally be taken together. Ara 290 and Ipamorelin work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols.

Is Ara 290 and Ipamorelin safe together?

Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: teratogenic. Monitor accordingly.

What are the interactions between Ara 290 and Ipamorelin?

Ara 290 and Ipamorelin work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time Ara 290 and Ipamorelin?

Ara 290 has a half-life of ~20 minutes (SubQ), ~2 minutes (IV) and Ipamorelin has a half-life of ~2 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Ara 290 vs Ipamorelin

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.